Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Lerman

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Israel Journal of Medical Sciences|April 1, 1994
Clinical, serological and molecular characteristics of 471 hepatitis B virus carriersS Bar-Shany, T Shohat, R Tur-Kaspa, et al.
International Journal of Impotence Research|September 18, 2009
Sexual activity and erectile dysfunction in elderly men with angiographically documented coronary artery diseaseD Justo, Y Arbel, B Mulat, et al.
Infection|May 1, 1993
Immunity to measles in young adults in IsraelY Lerman, S Riskin-Mashiach, D Cohen, et al.
Antimicrobial Agents and Chemotherapy|August 10, 2011
Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation centerP Espinal, G Fugazza, Y López, et al.
International Journal of Epidemiology|October 1, 1994
Sex differences in the humoral antibody response to live measles vaccine in young adultsM S Green, T Shohat, Y Lerman, et al.
Vaccine|November 1, 1994
Safety and immunogenicity of the oral E. coli K12-S. flexneri 2a vaccine (EcSf2a-2) among Israeli soldiersD Cohen, S Ashkenazi, M S Green, et al.
Infection and Immunity|September 1, 1993
Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoidsD N Taylor, A C Trofa, J Sadoff, et al.
Cancer Causes & Control : CCC|July 6, 2000
A graded work site intervention program to improve sun protection and skin cancer awareness in outdoor workers in IsraelE Azizi, P Flint, S Sadetzki, et al.
Israel Journal of Medical Sciences|May 1, 1994
A trial of the reactogenicity and immunogenicity of an inactivated hepatitis A vaccineM S Green, D Cohen, Y Lerman, et al.
The Journal of Infectious Diseases|September 1, 1993
Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulinM S Green, D Cohen, Y Lerman, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Israel Journal of Medical Sciences|April 1, 1994
Clinical, serological and molecular characteristics of 471 hepatitis B virus carriersS Bar-Shany, T Shohat, R Tur-Kaspa, et al.
International Journal of Impotence Research|September 18, 2009
Sexual activity and erectile dysfunction in elderly men with angiographically documented coronary artery diseaseD Justo, Y Arbel, B Mulat, et al.
Infection|May 1, 1993
Immunity to measles in young adults in IsraelY Lerman, S Riskin-Mashiach, D Cohen, et al.
Antimicrobial Agents and Chemotherapy|August 10, 2011
Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation centerP Espinal, G Fugazza, Y López, et al.
International Journal of Epidemiology|October 1, 1994
Sex differences in the humoral antibody response to live measles vaccine in young adultsM S Green, T Shohat, Y Lerman, et al.
Vaccine|November 1, 1994
Safety and immunogenicity of the oral E. coli K12-S. flexneri 2a vaccine (EcSf2a-2) among Israeli soldiersD Cohen, S Ashkenazi, M S Green, et al.
Infection and Immunity|September 1, 1993
Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoidsD N Taylor, A C Trofa, J Sadoff, et al.
Cancer Causes & Control : CCC|July 6, 2000
A graded work site intervention program to improve sun protection and skin cancer awareness in outdoor workers in IsraelE Azizi, P Flint, S Sadetzki, et al.
Israel Journal of Medical Sciences|May 1, 1994
A trial of the reactogenicity and immunogenicity of an inactivated hepatitis A vaccineM S Green, D Cohen, Y Lerman, et al.
The Journal of Infectious Diseases|September 1, 1993
Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulinM S Green, D Cohen, Y Lerman, et al.
Pageof 11